These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32605973)

  • 1. Cytokines and the still-baffling clinical biology of COVID-19.
    Mandell BF
    Cleve Clin J Med; 2020 Jun; 87(7):381-382. PubMed ID: 32605973
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?
    Miossec P
    Arthritis Rheumatol; 2020 Dec; 72(12):1963-1966. PubMed ID: 32725790
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine "storm", cytokine "breeze", or both in COVID-19?
    Lippi G; Plebani M
    Clin Chem Lab Med; 2020 Dec; 59(4):637-639. PubMed ID: 33554554
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine Release Syndrome Biology and Management.
    Cobb DA; Lee DW
    Cancer J; 2021 Mar-Apr 01; 27(2):119-125. PubMed ID: 33750071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of the cytokine storm in COVID-19.
    Wright DJM
    Lancet Infect Dis; 2021 Jan; 21(1):25-26. PubMed ID: 32386610
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm.
    Yang X; You J; Wei Y; Li H; Gao L; Guo Q; Huang Y; Gong C; Yi C
    J Mater Chem B; 2021 Oct; 9(39):8185-8201. PubMed ID: 34528037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 9. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.
    Iqubal A; Hoda F; Najmi AK; Haque SE
    Drug Res (Stuttg); 2021 Apr; 71(4):173-179. PubMed ID: 33434935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
    Hong R; Zhao H; Wang Y; Chen Y; Cai H; Hu Y; Wei G; Huang H
    Bone Marrow Transplant; 2021 Mar; 56(3):570-580. PubMed ID: 32943758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Storm.
    Fajgenbaum DC; June CH
    N Engl J Med; 2020 Dec; 383(23):2255-2273. PubMed ID: 33264547
    [No Abstract]   [Full Text] [Related]  

  • 13. Is IL-6 a key cytokine target for therapy in COVID-19?
    Jones SA; Hunter CA
    Nat Rev Immunol; 2021 Jun; 21(6):337-339. PubMed ID: 33850327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is a Cytokine Storm and Should It Matter to Me?
    Simkin J; Strange T; Leblanc N; Rivera JC
    J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy.
    Martín-Antonio B
    Front Immunol; 2021; 12():666703. PubMed ID: 33815428
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
    Hakim NN; Chi J; Olazagasti C; Liu JM
    Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccination and cancer immunotherapy: should they stick together?
    Brest P; Mograbi B; Hofman P; Milano G
    Br J Cancer; 2022 Jan; 126(1):1-3. PubMed ID: 34799696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients.
    Samsami M; Fatemi A; Jalili Khoshnoud R; Kohansal K; Hussen BM; Soghala S; Taheri M; Ghafouri-Fard S
    J Mol Neurosci; 2022 Jan; 72(1):27-36. PubMed ID: 34855144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
    Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling Cytokine Storm Is Vital in COVID-19.
    Tang L; Yin Z; Hu Y; Mei H
    Front Immunol; 2020; 11():570993. PubMed ID: 33329533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.